Assoc. Prof. ÇİĞDEM USUL AFŞAR

Metrics

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

137

H-Index (WoS)

Citation (Scopus)

133

H-Index (Scopus)

Open Access

UN Sustainable Development Goals

Education

2010 - 2014

Post Doctorate of Medicine

Cukurova University, Tıp Fakültesi, İç Hastalıkları (Tıbbi Onkoloji), Turkey

2004 - 2010

Expertise In Medicine

Sbü İstanbul Eğitim Ve Araştırma Hastanesi, İç Hastalıkları, İç Hastalıkları, Turkey

2002 - 2004

Postgraduate

İstanbul University-Cerrahpaşa, Tıp Fakültesi, Farmakoloji, Turkey

1995 - 2001

Undergraduate

İstanbul University-Cerrahpaşa, Tıp Fakültesi, Turkey

Foreign Languages

C1 Advanced

English

Research Areas

Medicine

Health Sciences

Internal Medicine Sciences

Internal Diseases

Oncology

Research Areas Based on Academic Activities

Avesis Research Areas

WoS Research Areas

Scopus Research Areas

Non Academic Experience

2023 - Continues

Tıbbi Onkoloji Eğitim ve İdari Sorumlusu

İSTANBUL EĞİTİM VE ARAŞTIRMA HASTANESİ, Tıbbi Onkoloji Eğitim ve İdari Sorumlusu

2010 - 2011

İç Hastalıkları Uzmanı

Esenyurt Devlet Hastanesi, İç Hastalıkları Uzmanı

Articles

2020

1. Evaluation of depression in patients with bone metastasis before and after radiotherapy

KARACA F., MENTEŞ S., USUL AFŞAR Ç., SERTDEMİR Y., ÇİL T.

Eastern Journal of Medicine , vol.25, no.1, pp.8-12, 2020 (Scopus, TRDizin)

2019

2. HIF-1α Levels in patients receiving chemoradiotherapy for locally advanced non-small cell lung carcinoma.

Afsar C., UYSAL P.

Revista da Associacao Medica Brasileira (1992) , vol.65, pp.1295-1299, 2019 (SCI-Expanded, Scopus)

2019

3. Syrian migrants with brain metastasis patients: Quality of life and anxiety before radiotherapy, depression before and after radiotherapy and the effect on familial relatives

Karaca F., CAVUS G., Afsar C. U., MENTES S., SERTDEMİR Y., GEZERCAN Y.

Eastern Journal of Medicine , vol.24, no.4, pp.412-421, 2019 (Scopus, TRDizin)

2019

4. ROLE OF INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3) IN THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA AND MONITORING TREATMENT RESPONSE

BADEMLER S., Ucuncu W. Z., Sari M., Yasasever C. T., Afsar C. U., Tastekin D.

ACTA MEDICA MEDITERRANEA , vol.35, no.1, pp.71-75, 2019 (SCI-Expanded, Scopus)

2019

5. IMMUNE MARKERS IN SURGICALLY RESECTED EARLY STAGE NON-SMALL CELL LUNG CANCER PATIENTS

UYSAL P., Kilic B., Demirkaya A., Afsar C. U., KARACA F.

ACTA MEDICA MEDITERRANEA , vol.35, no.1, pp.65-69, 2019 (SCI-Expanded, Scopus)

2018

6. Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer

Afsar C. U., Karabulut M., Karabulut S., Ozal S. T., Cikot M., SERİLMEZ M., et al.

BIOMOLECULES , vol.8, no.4, 2018 (SCI-Expanded, Scopus)

2017

7. Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer.

KARABULUT M., Afsar C., ALıS H., ORAN E., KARABULUT S., AKARSU C., et al.

Molecular and clinical oncology , vol.7, pp.787-797, 2017 (ESCI, Scopus)

2017

8. Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.

Usul A., KARABULUT M., KARABULUT S., ALıS H., GONENC M., DAGOGLU N., et al.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy , vol.23, pp.196-200, 2017 (SCI-Expanded, Scopus)

2017

9. THE EFFECT OF PRETREATMENT NEUTROPHIL/LEUCOCYTE RATIO ON SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL CANCER RECEIVING CHEMORADIOTHERAPY

KARACA F., Afsar C. U., Almalı N., KARABULUT S., KARABULUT M., Keskin S., et al.

ACTA MEDICA MEDITERRANEA , vol.33, no.6, pp.905-911, 2017 (SCI-Expanded, Scopus)

2017

10. SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA

KARABULUT M., Afsar C. U., KARABULUT S., PEKER K. D., GEMICI E., Dagoglu N., et al.

ACTA MEDICA MEDITERRANEA , vol.33, no.4, pp.613-619, 2017 (SCI-Expanded, Scopus)

2017

11. CIRCULATING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1/CCL-2) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA

Afsar C. U., KARABULUT M., Karabulut S., ALIS H., BINBOGA S., Bilgin E., et al.

ACTA MEDICA MEDITERRANEA , vol.33, no.3, pp.501-507, 2017 (SCI-Expanded, Scopus)

2016

12. Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma

Karabulut S., Afsar C. U., KARABULUT M., ALIS H., BOZKURT M. A., Aydogan F., et al.

BBA CLINICAL , vol.6, pp.138-142, 2016 (ESCI, Scopus)

2016

13. Chemotherapy and Radiation Induced Pulmonary Dysfunction in Hodgkin Lymphoma Patients.

GUNER S., YANMAZ M., SELVI A., Usul C.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion , vol.32, pp.431-436, 2016 (SCI-Expanded, Scopus)

2016

14. Clinical significance of serum interleukin-17 levels in colorectal cancer patients

Karabulut S., Afsar C. U., KARABULUT M., Kilic L., ALIS H., KONES O., et al.

JOURNAL OF BUON , vol.21, no.5, pp.1137-1145, 2016 (SCI-Expanded, Scopus)

2016

15. Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy

Karabulut S., Afsar C. U., KARABULUT M., ALIS H., Erturk K., KARAMAN Ş., et al.

JOURNAL OF BUON , vol.21, no.4, pp.895-902, 2016 (SCI-Expanded, Scopus)

2016

16. The High Effect of Chemomobilization with High-Dose Etopside + Granulocyte-Colony Stimulating Factor in Autologous Hematopoietic Peripheral Blood Stem Cell Transplantation: A Single Center Experience.

GUNER S., YANMAZ M., SELVI A., Usul C.

Hematology reports , vol.8, pp.6319, 2016 (ESCI, Scopus)

2016

17. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma

KARABULUT M., GUNALDI M., ALIS H., Afsar C. U., Karabulut S., SERİLMEZ M., et al.

CLINICAL & TRANSLATIONAL ONCOLOGY , vol.18, no.2, pp.160-171, 2016 (SCI-Expanded, Scopus)

2016

18. Clinical outcomes and prognostic factors of adult's Ewing sarcoma family of tumors: single center experience

Uyeturk U., HELVACI K., DEMIRCI A., SONMEZ O. U., TURKER I., Afsar C. U., et al.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.2, pp.141-146, 2016 (ESCI, Scopus)

2016

19. CIRCULATING MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (MIP1-A) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PATIENTS WITH PANCREATIC ADENOCARCINOMA

Karabulut S., Afsar C. U., KARABULUT M., ALIS H., BINBOGA S., OZKARA I. O., et al.

ACTA MEDICA MEDITERRANEA , vol.32, no.4, pp.1035-1040, 2016 (SCI-Expanded, Scopus)

2016

20. CLINICAL SIGNIFICANCE OF SERUM HEPATOCYTE GROWTH FACTOR (HGF) AND ITS RECEPTOR CMET LEVELS IN COLORECTAL CANCER PATIENTS

KARABULUT M., ALIS H., GÜNALDI M., Afsar C. U., Karabulut S., KONES O., et al.

ACTA MEDICA MEDITERRANEA , vol.32, no.1, pp.179-187, 2016 (SCI-Expanded, Scopus)

2015

21. Efficacy of paclitaxel in the treatment of Kaposi sarcoma

ERCOLAK V., ŞAHİN B., GUNALDI M., DUMAN B. B., Afsar C. U.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.19, no.21, pp.4095-4100, 2015 (SCI-Expanded, Scopus)

2015

22. Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer

KARABULUT M., ALIS H., BAS K., Karabulut S., Afsar C. U., Oguz H., et al.

MOLECULAR AND CLINICAL ONCOLOGY , vol.3, no.6, pp.1255-1267, 2015 (ESCI, Scopus)

2015

23. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer

KARABULUT M., ALIS H., Afsar C. U., Karabulut S., KOCATAS A., Oguz H., et al.

BIOMEDICINE & PHARMACOTHERAPY , vol.73, pp.140-146, 2015 (SCI-Expanded, Scopus)

2015

24. Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws

GUNALDI M., AFSAR C. U., DUMAN B. B., KARA İ. O., TATLI U., ŞAHİN B.

ONCOLOGY LETTERS , vol.10, no.1, pp.439-442, 2015 (SCI-Expanded, Scopus)

2015

25. Retrospective Evaluation of the Pancreatic Cancer Patients Who Received Chemoradiotherapy

KARACA F., Afsar C. U., OKTEM O., ALMALI N., Yilmazer G., Keskin S., et al.

JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE , vol.6, pp.327-332, 2015 (ESCI, TRDizin)

2015

26. Elevated Serum Levels of Heat Shock Protein 70 Are Associated with Breast Cancer

GÜNALDI M., Afsar C. U., OKUTURLAR Y., GEDİKBAŞI A., KOCOGLU H., KURAL A., et al.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE , vol.236, no.2, pp.97-102, 2015 (SCI-Expanded, Scopus)

2015

27. CLINICAL SIGNIFICANCE OF CIRCULATING PROINFLAMMATORY CYTOKINE LEVELS IN PATIENTS WITH PANCREATIC ADENOCARCINOMA

USUL AFŞAR Ç.

İstanbul Tıp Dergisi , vol.78, no.4, pp.102-109, 2015 (TRDizin)

2015

28. Retrospective Analysis of 119 Osteosarcomas in a Single Centre Experience

GÜNALDI M., DUMAN B. B., Ercolak V., Afsar C. U., PAYDAŞ S., ERKISI M., et al.

JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE , vol.6, pp.117-120, 2015 (ESCI, TRDizin)

2015

29. Diffuse Large B Cell Lymphoma of the Breast

USUL AFŞAR Ç.

ÇUKUROVA ÜNİVERSİTESİ EĞİTİM FAKÜLTESİ DERGİSİ , vol.40, no.1, pp.151-157, 2015 (TRDizin)

2015

30. THE EFFECT OF CHEMORADIOTHERAPY ON SURVIVAL IN LOCALLY ADVANCED UNRESECTABLE NON-SMALL CELL LUNG CANCER PATIENTS: EXPERIENCE FROM THE SOUTHEAST REGION OF TURKEY

Afsar C. U., Karaca F., Gunaldi M., KARA İ. O., Erkisi M., ŞAHİN B., et al.

ACTA MEDICA MEDITERRANEA , vol.31, no.4, pp.883-888, 2015 (SCI-Expanded, Scopus)

2015

31. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung

Afsar C. U., ŞAHİN B., GÜNALDI M., BAGIR E. K., GÜMÜRDÜLÜ D., BURGUT R., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY , vol.8, no.9, pp.9760-9771, 2015 (SCI-Expanded, Scopus)

2015

32. Palliative Radiotherapy for Spinal Extramedullary Hematopoiesis in Thalassemia Major

FERYAL k., USUL AFŞAR Ç., SERT F., ŞEBNEM i. g., ERÇOLAK V., ERKURT E., et al.

International Blood Research Reviews , vol.3, no.3, 2015 (Peer-Reviewed Journal)

2015

33. Diffuse Large B Cell Lymphoma of the Breast

Karaca F., Ercolak V., USUL AFŞAR Ç., Gunaldi M.

CUKUROVA MEDICAL JOURNAL , vol.40, no.1, pp.151-157, 2015 (ESCI, TRDizin)

2015

34. Paraoxonase-1 and arylesterase activities in patients with colorectal cancer

Afsar C. U., GÜNALDI M., OKUTURLAR Y., GEDİKBAŞI A., TIKEN E. E., KAHRAMAN S., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.8, no.11, pp.21599-21604, 2015 (SCI-Expanded, Scopus)

2015

35. Using Pazopanib and Radiotherapy to Treat Metastatic Renal Cell Carcinoma with Acrometastases

USUL AFŞAR Ç., PAYDAŞ S.

International Journal of Medical and PharmaceuticalCase Reports , 2015 (Peer-Reviewed Journal)

2015

36. PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma

ERCOLAK V., PAYDAŞ S., BAGIR E., ERGİN M., SEYDAOĞLU G., CELIK H., et al.

ACTA HAEMATOLOGICA , vol.134, no.4, pp.199-207, 2015 (SCI-Expanded, Scopus)

2015

37. Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers

Karaca F., Afsar C. U., Gunaldi M., Erkurt E., Ercolak V., SERTDEMİR Y., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.8, no.1, pp.876-882, 2015 (SCI-Expanded, Scopus)

2014

38. A New Approach to the Treatment of Metastatic Paraganglioma: Sorafenib

GUNALDI M., KARA İ. O., DUMAN B. B., AFSAR C. U., ERGIN M., AVCI A.

CANCER RESEARCH AND TREATMENT , vol.46, no.4, pp.411-414, 2014 (SCI-Expanded, Scopus)

2014

39. Abdominal actinomycosis with multiple myeloma: A case report

Ercolak V., PAYDAŞ S., ERGİN M., Ates B. T., Duman B. B., Gunaldi M., et al.

ONCOLOGY LETTERS , vol.8, no.4, pp.1876-1878, 2014 (SCI-Expanded, Scopus)

2014

40. Bilateral Primary Adrenal Non-Hodgkin Lymphoma

Ercolak V., Kara O., Gunaldi M., USUL AFŞAR Ç., Duman B. B., AÇIKALIN A., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.31, no.2, pp.205-206, 2014 (SCI-Expanded, Scopus, TRDizin)

2014

41. Temporal kemik yerleşimli langerhans hücreli histiositosis Bir olgu sunumu

MERAL g., BERNA d. b., USUL AFŞAR Ç., ÖMÜR g., ŞAHİN B.

Göztepe Tıp Dergisi , vol.29, no.2, pp.121-123, 2014 (TRDizin)

2014

42. Primary Spinal Glioblastoma Multiforme: A Case Report and Review of The Literature

KARACA F., Afsar C. U., Erkurt E., TUNALI C., ARSLANTAŞ H. S., KOCABAS C.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , vol.31, no.2, pp.366-376, 2014 (SCI-Expanded, Scopus, TRDizin)

2014

43. Evaluation of CYP2D6 Polymorphic Types and Their Effect on Tamoxifen Efficacy Among Turkish Tamoxifen Users with Breast Cancer

Gunaldi M., Erkisi M., Afsar C., Ercolak V., Duman B., PAYDAŞ S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.3, pp.157-162, 2014 (SCI-Expanded, Scopus, TRDizin)

2014

44. Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment

Gunaldi M., Erkisi M., Afsar C. U., Ercolak V., PAYDAŞ S., KARA İ. O., et al.

PHARMACOLOGY , vol.94, pp.183-189, 2014 (SCI-Expanded, Scopus)

2014

45. Pancreatic Carcinoma, Thrombosis and Mean Platelet Volume: Single Center Experience from the Southeast Region of Turkey

Afsar C. U., Gunaldi M., KUM P., Sahin B., Erkisi M., Kara I. O., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.21, pp.9143-9146, 2014 (SCI-Expanded, Scopus)

2013

46. Large Granüler Lenfositik Lösemi

USUL AFŞAR Ç., ARSLANTAŞ H. S., ŞAHİN B.

Türkiye Klinikleri J Hematol-Special Topics , vol.6, no.1, pp.27-33, 2013 (Peer-Reviewed Journal)

2012

47. Sorafenib İlişkili Üç Farklı Deri Toksisitesi Olgu Sunumu

MERAL g., BOZKURT DUMAN b., ERÇOLAK V., USUL AFŞAR Ç., KARA İ. O., ŞAHİN B.

Turkish Journal Of Dermatology , vol.6, pp.17-20, 2012 (Peer-Reviewed Journal)

2010

48. Evaluation of the use of human albumin solution in Gaziosmanpaşa University Faculty of Medicine Hospital

ÜYETÜRK Ü., ÖZBEY G., ÜYETÜRK U., USUL AFŞAR Ç.

Yeni Tıp Dergisi , vol.27, no.3, pp.165-168, 2010 (TRDizin)

2009

49. Akut pulmoner emboli

FATMA a. ö., YURDAKUL S., USUL AFŞAR Ç., EGEMEN c., MECDİ e.

SB İstanbul Eğitim ve Araştırma hsatensi Tıp Dergisi , vol.10, pp.33-36, 2009 (Non Peer-Reviewed Journal)

2008

50. Pulomoner tromboembolide ekokardiyografi multidedektörlü BT anjiyografi ve trombolitik tedavinin yeri Olgu Sunumu

ÜYETÜRK Ü., USUL AFŞAR Ç., ÖCAL S.

MN Dahili Tıp Bilimleri , vol.3, no.2, pp.99-102, 2008 (Peer-Reviewed Journal)

2007

51. A young patient who had ventricular tachycardia after an sports activity case report

YURDAKUL S., USUL AFŞAR Ç.

J Of Electrocardiology , vol.40, no.4, pp.28, 2007 (Peer-Reviewed Journal)

2007

52. Atipik lokalizasyonlu bir Castleman hastalığı olgusu

GÖKÇEN g., USUL AFŞAR Ç., CÜNEYT m., POLAT h., HANİFE u., AKSOY ş., et al.

SB İstanbul Eğitim ve Araştırma Hastanesi , vol.8, no.4, pp.43-44, 2007 (Non Peer-Reviewed Journal)

2006

53. Aort kapak sendromlu bir hastada brucella endokarditi bir olgu sunumu

USUL AFŞAR Ç., CÜNEYT m., ÖZGÜL ÖZDEMİR r. b., GÖKÇEN g., POLAT h.

SB İstanbul Eğitim ve Araştırma Hastanesi , vol.7, no.2, pp.34-36, 2006 (Non Peer-Reviewed Journal)

2006

54. Çinko eksikliği ve anemi bir olgu sunumu

MÜZEYYEN b., USUL AFŞAR Ç., KEZBAN NUR p., SEVDA g., MEHMET EMİN p., MECDİ e.

İstanbul Medical Journal , vol.7, pp.38-39, 2006 (ESCI, TRDizin)

2005

55. Kliniğimize yatırılan üst gis kanamalı hastalarımızın değerlendirilmesi

HASAN a., HANİFE u., HALE k., FÜSUN e., USUL AFŞAR Ç., CÜNEYT m., et al.

SB İstanbul Eğitim Hastanesi Tıp Dergisi , vol.6, no.4, pp.7-10, 2005 (Non Peer-Reviewed Journal)

Papers Presented at Peer-Reviewed Scientific Conferences

2022

1. Yeni Nesil Dizileme Temelli NTRK Füzyon Çalışmalarında FFPE Doku ve Likit Biyopsi Örneği Seçimlerinde Klinik Yönelimler ve Sonuçların Kümülatif Değerlendirilmesi

BİŞGİN A., Müjde C., BOGA İ., SÖNMEZLER Ö., YAVUZ S., KÖSE F., et al.

9. Türk Tıbbi Onkoloji Kongresi, Girne, Cyprus (Kktc), 18 May 2022, (Summary Text)

2019

2. Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study

Karabulut S., DOĞAN İ., AK N., Afsar C. U., KARABULUT M., Tastekin D.

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30, pp.305, (Summary Text)

2016

3. The blood neutrophil/lymphocyte ratio in breast cancer

KORO A., ARAL H., GURSU R. U., TRABULUS D. C., NAZLI M. A., Afsar C. U., et al.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.256-257, (Summary Text)

2016

4. Diagnostic and prognostic roles of serum interleukin-32 (IL-32) levels in patients with pancreatic adenocarcinoma.

KARABULUT S., Afsar C. U., YASASEVER V., KARABULUT M., ERTURK K., ALIS H., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34, (Summary Text)

2015

5. The effect of platinum and docetaxel based chemoradiotherapy on survival in locally advanced unresectable non-small cell lung cancer patients.

AFSAR C. U., GUNALDI M., KARACA F., Kara I. O., Sahin B., DUMAN B. B., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33, (Summary Text)

2015

6. Tuberoskleroz ve malign melanom birlikteliği

MERAL g., PAYDAŞ S., USUL AFŞAR Ç., ERÇOLAK V., BOZKURT DUMAN b., DORAN F.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 April 2015

2015

7. Can Heat Shock Protein 70 be a Target Therapy in Breast Cancer

GÜNALDI m., USUL AFŞAR Ç., OKUTURLAR y., GEDİKBAŞI a., ALEV k., GÜNDÜZ u.

International Symposium on Advances In Predictive and Personalized Medicine, 2 - 03 April 2015

2015

8. Paraoxonase and Arylesterase Activities in Patients with Coloractal Cancer

USUL AFŞAR Ç., meral g., yıldız o., asuman g., alev k.

International Symposium on Advances In Predictive And Personalized Medicine, 2 - 03 April 2015

2014

9. The evaluation of fibroblast growth factor receptor 1 FGFR1 fibroblast growth factor 2 FGF2 phosphatidylinositol 3 phosphate kinase IP3K expression and Their Clinical Prognostic Significance in Early and Advanced Stage of Squamous Cell Carcinoma of The Lung

USUL AFŞAR Ç., ŞAHİN B., GÜMÜRDÜLÜ D., KILIÇ BAĞIR E., BURGUT H. R., KÖKSAL ERKİŞİ M., et al.

ESMO 2014, 26 - 30 September 2014

2014

10. The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment.

USUL AFŞAR Ç.

ASCO, Chicago, United States Of America, 30 May - 03 June 2014, vol.32, no.15, (Full Text)

2014

11. The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment.

GUNALDI M., ERKISI M., AFSAR C. U., ERCOLAK V., Paydas S., Kara I. O., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32, (Summary Text)

2013

12. Özafagus Kanserli 64 Hasta

USUL AFŞAR Ç., ŞAHİN B., KARA İ. O., MERAL g., BERNA b. d., KUM p., et al.

10. Ulusal Tıbbi Onkoloji Kongresi., Turkey, 11 - 15 September 2013

2013

13. Nonalcoholic fatty liver disease after adjuvant therapy in nonmetastatic breast cancer.

Duman B. B., Gunaldi M., Tasdogan B. E., Afsar C. U., Paydas S., Gumurdulu Y.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text)

2013

14. Meme Kanserli Hastalarda Adjuvant Neoadjuvant Doz Dense Kemoterapi Deneyimimiz

BERNA b. d., USUL AFŞAR Ç., MERAL g., KÖKSAL ERKİŞİ M., KARA İ. O., ŞAHİN B., et al.

20. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2013

2013

15. Çukurova Üniversitesi Tıp Fakültesi nde Tanı Konulmuş Pankreas Kanserli Hastalarımızın Retrospektif Olarak Değerlendirilmesi ve Derin Ven Trombozu İle Metastaz Yeri Ve Ortalama Trombosit Hacmi Arasındaki İlişkinin İncelenmesi

USUL AFŞAR Ç., KUM p., ŞAHİN B., BOZKURT DUMAN b., GÜNALDI m., ERÇOLAK V., et al.

20. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2013

2012

16. Akromegaliye Eşlik Eden Malign Mezankimal Tümör

MERAL g., KARA İ. O., USUL AFŞAR Ç., ERÇOLAK V., BERNA b. d.

9. Ulusal Tıbbi Onkoloji Kongresi, Turkey, 12 - 16 September 2012

2012

17. Sorafenib in the treatment of metastatic paraganglioma: A case report.

Gunaldi M., Kara I. O., Afsar C. U., Duman B. B.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30, (Summary Text)

2012

18. Kanser kayıt merkezimizdeki kayıtlı pankreas kanserli 73 hastanın özelliklerinin değerlendirilmesi

KUM p., ŞAHİN B., USUL AFŞAR Ç.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

19. Kapesitabin ilişkili ciddi hipertrigliseridemi 2 olgu sunumu

BERNA b. d., PAYDAŞ S., MERAL g., USUL AFŞAR Ç., ERÇOLAK V., TETİKER B. T., et al.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

20. Nüks glioblastome multiformeli bir hastada irinotekan bevacizumab fenitoin ilaç etkileşimi olarak hepatotoksisite

USUL AFŞAR Ç., ŞAHİN B., KARA İ. O., KÖKSAL ERKİŞİ M., BERNA b. d., MERAL g., et al.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

21. Bilateral over metastazı ile tanı konan primer appendiks adenokarsinomu

USUL AFŞAR Ç., KARA İ. O., SAKMAN G., PARSAK C. K., GÜMÜRDÜLÜ D., BERNA b. d., et al.

4. Tıbbi Onkoloji Derneği, Turkey, 21 - 25 March 2012

2012

22. HER 2 pozitif meme kanserinde PTEN AKT MAPK P 53 ekspresyonunun neoadjuvan tedavi sonrası patolojik tam yanıta ve sağkalıma etkisi

BERNA b. d., ŞAHİN B., ERGİN M., MERAL g., USUL AFŞAR Ç., ERÇOLAK V., et al.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

23. Bilateral primer adrenal non hodgkin lenfoma

ERÇOLAK V., KARA İ. O., MERAL g., USUL AFŞAR Ç., ERDOĞAN Ş., ERGİN M., et al.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

24. Genç bir erkek hastada yumuşak doku malign myoepitelyoması

USUL AFŞAR Ç., PAYDAŞ S., GÖNLÜŞEN G., GÖNLÜŞEN G., meral g., ERÇOLAK V., et al.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

25. Akciğer Karsinomlu Hastada alfa 2 globulin piki

MERAL g., KÖKSAL ERKİŞİ M., USUL AFŞAR Ç., BERNA b. d., ERÇOLAK V.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

26. Erişkin Wilms Tümörü

ERÇOLAK V., KARA İ. O., USUL AFŞAR Ç., MERAL g., ERDOĞAN Ş., BERNA t. a.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

27. Metastatik renal hücreli karsinomda sitoredüktif nefrektominin sağkalım üzerine etkisi

BERNA b. d., ŞAHİN B., KÖKSAL ERKİŞİ M., PAYDAŞ S., KARA İ. O., USUL AFŞAR Ç., et al.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

28. Trastuzumab İlişkili kardiyotoksisiteye epirubisin ve doxorubisin katkısının karşılaştırması

MERAL g., BERNA b. d., ERÇOLAK V., USUL AFŞAR Ç., PAYDAŞ S., KARA İ. O., et al.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

29. Akciğer Sarkomatoid Karsinomunun bir alt tipi Pulmoner Blastom

USUL AFŞAR Ç., PAYDAŞ S., GÜMÜRDÜLÜ D., GÜNALDI m., ERÇOLAK V.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

30. Hematolojik malignitelerde endometrium over ve serviks tutulumu

USUL AFŞAR Ç., KARA İ. O., MERAL g., BERNA b. d., ERÇOLAK V.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

31. Gemsitabin İlişki Dress Sendromu Bir olgu nedeniyle

ERTUĞRUL b., PAYDAŞ S., ZORLUDEMİR S., ABDURRAHMAN d., AÇIKALIN A., USUL AFŞAR Ç., et al.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

32. Richter sendromu

MERAL g., KÖKSAL ERKİŞİ M., USUL AFŞAR Ç., BERNA b. d., ERÇOLAK v.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

33. Larenks epidermoid karsinom ve malign fibröz histiositom birlikteliği Larenkste bir sarkomatoid karsinom

USUL AFŞAR Ç., KÖKSAL ERKİŞİ M., UĞUZ A. H., BERNA t. a., ARBİL AVCI a., MERAL g., et al.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

34. Muir Torre Sendromu

USUL AFŞAR Ç., KARA İ. O., MERAL g., BERNA b. d., ERÇOLAK V., PARSAK C. K., et al.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

35. Kanser Kayıt Merkezimizde Kayıtlı Akciğer Kanserli 135 Kadın Hastanın Tedavi ve Sağkalım Sonuçları

KUM p., ŞAHİN B., USUL AFŞAR Ç.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2012

36. Meme kanserli bir vakada TTF 1 pozitifliği

USUL AFŞAR Ç., PAYDAŞ S., GÜMÜRDÜLÜ D., MERAL g., ERÇOLAK V., AÇIKALIN A.

4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

2011

37. Çukurova Üniversitesi Kanser Kayıt Merkezinde kayıtlı 47 erkek meme kanserli vakanın özelliklerinin değerlendirilmesi

KUM p., ŞAHİN B., USUL AFŞAR Ç.

11. Ulusal Meme Hastalıkları Kongresi, Turkey, 5 - 09 October 2011

Books

2019

1. Novel Strategies and Approaches in Hypertension Therapy

USUL AFŞAR Ç., ÖZYAZGAN S.

in: Bentham Books, , Editor, Bentham Science Publishers, 2019

2014

2. Yüksek Dereceli Gliomlarda Etyoloji ve Risk Faktörleri

USUL AFŞAR Ç., ŞAHİN B.

in: Klinik Tıp Bilimleri, Ömür Günaldı, Editor, Selen Yayıncılık, 2014

Activities in Scientific Journals

2019 - Continues

CPQ Cancer

Committee Member

2019 - Continues

Eurasian Journal of Clinical Investigation

Committee Member

Memberships and Roles in Scientific Organizations

2019 - Continues

Interdisipliner Onkoloji Derneği (IDOD)

Board Member

2019 - Continues

Türk Tıbbi Onkoloji Derneği

Member

2017 - Continues

Türk Tabipler Birliği

Member

2014 - Continues

ESMO (European Society of Medical Oncology)

Member

Congress and Symposium Activities

01 December 2019 - 01 December 2019

9th INTERNATIONAL GASTROINTESTINAL CANCER CONFERENCE

Attendee

İstanbul-Turkey

01 November 2019 - 01 November 2019

6th MEDMOF AND 3rd ICONS

Attendee

Antalya-Turkey

01 October 2019 - 01 October 2019